Revaccination with marek's disease vaccines induces productive infection and superior immunity

Clinical and Vaccine Immunology

Volumn 16, Issue 2, 2009, Pages 184-193

  Wu, Changxin ^a,e   Gan, Junji ^a   Jin, Qiao ^a   Chen, Chuangfu ^b   Liang, Ping ^a   Wu, Yantao ^a   Liu, Xuefen ^a   Li, Ma ^d   Davison, Fred ^c  

^a YANGZHOU UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^d Research Centre   (China)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAREK DISEASE VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIRD DISEASE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; REVACCINATION; VIRUS CELL INTERACTION; VIRUS IMMUNITY;

ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CHICKENS; FLOW CYTOMETRY; IMMUNIZATION, SECONDARY; LYMPHOCYTE SUBSETS; MAREK DISEASE; MAREK DISEASE VACCINES; NEUTRALIZATION TESTS;

EID: 59649116070     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00201-08     Document Type: Article

References (41)

1. 1 matings. J. Hered. 86:269-273.
2. Baigent, S. J., L. P. Smith, V. K. Nair, and R. J. Currie. 2006. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection. Vet. Immunol. Immunopathol. 112:78-86.
3. Barrow, A. D., S. C. Burgess, S. J. Baigent, K. Howes, and V. K. Nair. 2003. Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus. J. Gen. Virol. 84:2635-2645.
4. Beasley, J. N., L. T. Patterson, and D. H. McWade. 1970. Transmission of Marek's disease by poultry house dust and chicken dander. Am. J. Vet. Res. 31:339-344.
5. Brown, A. C., S. J. Baigent, L. P. Smith, J. P. Chattoo, L. J. Petherbridge, P. Hawes, M. J. Allday, and V. Nair. 2006. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc. Natl. Acad. Sci. USA 103:1687-1692.
6. Burgess, S. C., and T. F. Davison. 1999. Counting absolute numbers of specific leukocyte subpopulations in avian whole blood using a single-step flow cytometric technique: comparison of two inbred lines of chickens. J. Immunol. Methods 227:169-176.
7. Burgess, S. C., J. R. Young, B. J. Baaten, L. Hunt, L. N. Ross, M. S. Parcells, P. M. Kumar, C. A. Tregaskes, L. F. Lee, and T. F. Davison. 2004. Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30). Proc. Natl. Acad. Sci. USA 101:13879-13884.
8. Burgoyne, G. H., and R. L. Witter. 1973. Effect of passively transferred immunoglobulins on Marek's disease. Avian Dis. 17:824-837.
9. Buscaglia, C., B. W. Calnek, and K. A. Schat. 1988. Effect of immunocom-petence on the establishment and maintenance of latency with Marek's disease herpesvirus. J. Gen. Virol. 69(Pt 5):1067-1077.
10. Calnek, B. W. 1972. Effects of passive antibody on early pathogenesis of Marek's disease. Infect. Immun. 6:193-198.
11. Calnek, B. W. 1973. Influence of age at exposure on the pathogenesis of Marek's disease. J. Natl. Cancer Inst. 51:929-939.
12. Calnek, B. W. 2001. Pathogenesis of Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 255:25-55.
13. Calnek, B. W., W. R. Shek, and K. A. Schat. 1981. Latent infections with Marek's disease virus and turkey herpesvirus. J. Natl. Cancer Inst. 66:585-590.
14. Calnek, B. W., T. Ubertini, and H. K. Adldinger. 1970. Viral antigen, virus particles, and infectivity of tissues from chickens with Marek's disease. J. Natl. Cancer Inst. 45:341-351.
15. Cho, B. R., and S. G. Kenzy. 1975. Horizontal transmission of turkey herpesvirus to chickens. 3. Transmission in three different lines of chickens. Poult. Sci. 54:109-115.
16. Churchill, A. E., R. C. Chubb, and W. Baxendale. 1969. The attenuation, with loss of oncogenicity, of the herpes-type virus of Marek's disease (strain HPRS-16) on passage in cell culture. J. Gen. Virol. 4:557-564.
17. Epstein, M. A. 2001. Historical background. Philos. Trans. R. Soc. Lond. B 356:413-420.
18. Fabricant, J., B. W. Calnek, and K. A. Schat. 1982. The early pathogenesis of turkey herpesvirus infection in chickens and turkeys. Avian Dis. 26:257-264.
19. Garcia-Camacho, L., K. A. Schat, R. Brooks, Jr., and D. I. Bounous. 2003. Early cell-mediated immune responses to Marek's disease virus in two chicken lines with defined major histocompatibility complex antigens. Vet. Immunol. Immunopathol. 95:145-153.
20. Higgins, D. A., and B. W. Calnek. 1976. Some effects of silical treatment on Marek's disease. Infect. Immun. 13:1054-1060.
21. Islam, A., and S. W. Walkden-Brown. 2007. Quantitative profiling of the shedding rate of the three Marek's disease virus (MDV) serotypes reveals that challenge with virulent MDV markedly increases shedding of vaccinal viruses. J. Gen. Virol. 88:2121-2128.
22. Jarosinski, K. W., B. K. Tischer, S. Trapp, and N. Osterrieder. 2006. Marek's disease virus: lytic replication, oncogenesis and control. Expert Rev. Vaccines 5:761-772.
23. Morimura, T., M. Hattori, K. Ohashi, C. Sugimoto, and M. Onuma. 1995. Immunomodulation of peripheral T cells in chickens infected with Marek's disease virus: involvement in immunosuppression. J. Gen. Virol. 76(Pt 12): 2979-2985.
24. Nazerian, K., and R. L. Witter. 1970. Cell-free transmission and in vivo replication of Marek's disease virus. J. Virol. 5:388-397.
25. Okazaki, W., H. G. Purchase, and B. R. Burmester. 1970. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14:413-429.
26. Omar, A. R., and K. A. Schat. 1997. Characterization of Marek's disease herpesvirus-specific cytotoxic T lymphocytes in chickens inoculated with a non-oncogenic vaccine strain of MDV. Immunology 90:579-585.
27. Payne, L. N., and M. Rennie. 1973. Pathogenesis of Marek's disease in chicks with and without maternal antibody. J. Natl. Cancer Inst. 51:1559-1573.
28. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-431.
29. Rispens, B. H., H. van Vloten, N. Mastenbroek, H. J. Maas, and K. A. Schat. 1972. Control of Marek's disease in The Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125.
30. Rispens, B. H., H. van Vloten, N. Mastenbroek, J. L. Maas, and K. A. Schat. 1972. Control of Marek's disease in The Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16:126-138.
31. Schat, K. A., and B. W. Calnek. 1978. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082.
32. Schat, K. A., and C. J. Markowski-Grimsrud. 2001. Immune responses to Marek's disease virus infection. Curr. Top. Microbiol. Immunol. 255:91-120.
33. Schat, K. A., and Z. Xing. 2000. Specific and nonspecific immune responses to Marek's disease virus. Dev. Comp. Immunol. 24:201-221.
34. Schmid, D. S., and A. C. Mawle. 1991. T cell responses to herpes simplex viruses in humans. Rev. Infect. Dis. 13(Suppl. 11):S946-S949.
35. Spencer, J. L., A. A. Grunder, A. Robertson, and G. W. Speckmann. 1972. Attenuated Marek's disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance. Avian Dis. 16:94-107.
36. Sugaya, K., G. Bradley, M. Nonoyama, and A. Tanaka. 1990. Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions. J. Virol. 64:5773-5782.
37. van Drunen Littel-van den Hurk, S., R. P. Braun, P. J. Lewis, B. C. Karvonen, M. E. Baca-Estrada, M. Snider, D. McCartney, T. Watts, and L. A. Babiuk. 1998. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J. Gen. Virol. 79(Pt 4):831-839.
38. van Drunen Littel-van den Hurk, S., R. P. Braun, B. C. Karvonen, T. King, D. Yoo, and L. A. Babiuk. 1999. Immune responses and protection induced by DNA vaccines encoding bovine parainfluenza virus type 3 glycoproteins. Virology 260:35-46.
39. Witter, R. L. 2001. Protective efficacy of Marek's disease vaccines. Curr. Top. Microbiol. Immunol. 255:57-90.
40. Witter, R. L., J. M. Sharma, L. F. Lee, H. M. Opitz, and C. W. Henry. 1984. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers. Avian Dis. 28:44-60.
41. Zanella, A., and F. Lombardini. 1996. Marek's disease in Italy: current strategies for control, p. 104-112. In R. F. Sila, H. H. Cheng, P. M. Cooussens, L. F. Lee, and L. F. Velicer (ed.), 5th International Symposium on Marek's Disease. Michigan State University, East Lansing.